WHY IT MATTERS: If state health authorities move forward with potency restrictions or new labeling requirements, patients who rely on higher-concentration products for legitimate medical purposes may face reduced access or need to significantly adjust their dosing strategies. CLINICAL OVERVIEW: Public health officials are raising concerns about the increasing potency of cannabis products available in the legal market, particularly regarding exposure among adolescents and young people. The discussion centers on how THC concentrations in modern products differ substantially from those in cannabis consumed decades ago, and what that means for developing brains.